TauTona Group is a vertically-integrated operational fund that creates, invests and develops new solutions in medtech, biotech and regenerative medicine that address unmet clinical needs in healthcare. With a strong belief that improvements in healthcare and cost reductions can only be achieved through innovation, TauTona’s sustainable investment model enables disruptive ideas to be evaluated, designed, tested and developed in an extremely economic manner benefitting all stakeholders: inventors, investors, doctors and, most importantly, patients. The fund was founded in 2010 by two Stanford School of Medicine professors and researchers focused on bioengineering, tissue regeneration, and stem cell therapeutic approaches.
TO COMMERCIALIZATION
FROM IDEATION
The Human Condition Needs All The Help It Can Get.
Which Is Where We Come In.
People
World-class team of doctors, researchers, engineers and entrepreneurs who have built several companies and medical devices.
Products
Valuable pipeline of leading-edge medtech, biotech and regenmed products that have the ability to enhance R&D and optimize portfolios for leading healthcare companies.
Process
Differentiated development process designed to de-risk projects from ideation to commercialization to optimize medical impact and financial returns.
Philosophy
TauTona’s contrarian approach provides the ideal investment platform to accelerate the development of medical devices.
Three Devices We’ve Developed To Help Humanity
Innovations we're working on
Pneumoperitoneum Assist Device TPAD
2024-09-20
BioBolt Surgical Stapler
2024-09-19
TauTona Wound Dressing (TWD)
2024-09-18
What interests us.
